Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (211-220 of 773) with videos related to

Pageof 78
Sort By:
Journal of the American Society of Nephrology : JASN|March 9, 2021
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin DepositsLadan Zand, S Vincent Rajkumar, Nelson Leung, et al.
Haematologica|May 12, 2004
Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control studyMichael A Thompson, Robert A Kyle, L Joseph Melton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Fracture risk with multiple myeloma: a population-based studyL Joseph Melton, Robert A Kyle, Sara J Achenbach, et al.
Leukemia|March 24, 2018
The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete responseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Antioxidants (Basel, Switzerland)|May 24, 2016
Antioxidant Efficacy of Litchi (Litchi chinensis Sonn.) Pericarp Extract in Sheep Meat NuggetsArun K Das, Vincent Rajkumar, Pramod K Nanda, et al.
Blood|November 21, 2012
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myelomaP Leif Bergsagel, María-Victoria Mateos, Norma C Gutierrez, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Bortezomib-induced acute interstitial nephritisWisit Cheungpasitporn, Nelson Leung, S Vincent Rajkumar, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
Pageof 78

Showing results (211-220 of 773) with videos related to

Sort By:
Pageof 78
Journal of the American Society of Nephrology : JASN|March 9, 2021
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin DepositsLadan Zand, S Vincent Rajkumar, Nelson Leung, et al.
Haematologica|May 12, 2004
Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control studyMichael A Thompson, Robert A Kyle, L Joseph Melton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Fracture risk with multiple myeloma: a population-based studyL Joseph Melton, Robert A Kyle, Sara J Achenbach, et al.
Leukemia|March 24, 2018
The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete responseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Antioxidants (Basel, Switzerland)|May 24, 2016
Antioxidant Efficacy of Litchi (Litchi chinensis Sonn.) Pericarp Extract in Sheep Meat NuggetsArun K Das, Vincent Rajkumar, Pramod K Nanda, et al.
Blood|November 21, 2012
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myelomaP Leif Bergsagel, María-Victoria Mateos, Norma C Gutierrez, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Bortezomib-induced acute interstitial nephritisWisit Cheungpasitporn, Nelson Leung, S Vincent Rajkumar, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
Pageof 78